Brain iron and ferritin in Parkinson’s and Alzheimer’s diseases

Jellinger, K., Paulus, W., Grundke-Iqbal, I., Riederer, P., Youdim, M. B. H.·1990·Journal of Neural Transmission - Parkinson's Disease and Dementia Section

DOI 10.1007/bf02252926

Cited by (445)

Items 101–200 of 445

In vivo MR evaluation of age-related increases in brain iron.
George Bartzokis, Jim Mintz, David L. Sultzer, Péter Marx, Jan Herzberg, Cathy Phelan, Stephen R. Marder · 1994 · PubMed Central
Trace and major elements in whole blood, serum, cerebrospinal fluid and urine of patients with Parkinson?s disease
Giovanni Forte, Beatrice Bocca, Oreste Senofonte, Francesco Petrucci, Livia Brusa, Paolo Stanzione, Silvana Zannino, Nicola Violante, Alessandro Alimonti, Giuseppe Sancesario · 2004 · Journal of Neural Transmission
Astrocytes, brain aging, and neurodegeneration
Hyman M. Schipper · 1996 · Neurobiology of Aging
In vivo evaluation of brain iron in Alzheimer's disease and normal subjects using MRI
George Bartzokis, David L. Sultzer, Jim Mintz, Lori E. Holt, Péter Marx, Cathy Phelan, Stephen R. Marder · 1994 · Biological Psychiatry
Increased Iron in the Substantia Nigra Compacta of the MPTP‐Lesioned Hemiparkinsonian African Green Monkey: Evidence from Proton Microprobe Elemental Microanalysis
James A. Temlett, Judith P. Landsberg, F. Watt, G. W. Orime · 1994 · Journal of Neurochemistry
Iron and Ferroptosis as Therapeutic Targets in Alzheimer's Disease
Andrew J Gleason, Ashley Ian Bush · 2020 · Neurotherapeutics
MRI evaluation of the basal ganglia size and iron content in patients with Parkinson's disease
P. Kosta, Maria I. Argyropoulou, Sofia Markoula, Spyridon Konitsiotis · 2005 · Journal of Neurology
Perturbed Iron Distribution in Alzheimer's Disease Serum, Cerebrospinal Fluid, and Selected Brain Regions: A Systematic Review and Meta-Analysis
Yunlong Tao, Yu Wang, Jack T. Rogers, Fudi Wang · 2014 · Journal of Alzheimer s Disease
The role of transition metals in the pathogenesis of Parkinson's disease.
E. Kienzl, L. Puchinger, K. Jellinger, W. Linert, H. Stachelberger, R. Jameson · 1995 · Journal of Neurological Sciences
Mapping metals in Parkinson's and normal brain using rapid-scanning x-ray fluorescence
Bogdan Florin Gh. Popescu, Martin J. George, Uwe Bergmann, A. Garachtchenko, Michael Kelly, Richard P.E. McCrea, Katharina Luening, Richard M. Devon, Graham Neil George, Akela D Hanson et al. · 2009 · Physics in Medicine and Biology
Iron deposition in Parkinson’s disease by quantitative susceptibility mapping
Qiqi Chen, Yi‐Ting Chen, Yue Zhang, Furu Wang, Hongchang Yu, Caiyuan Zhang, Zhen Jiang, Weifeng Luo · 2019 · BMC Neuroscience
Gaucher’s disease with Parkinson’s disease
Bruno Bembi, Sandro Zambito Marsala, Ellen Sidransky, Giovanni Ciana, Marco Carrozzi, Marino Zorzon, Cleber Costa de Martini, Manuela Gioulis, María Gabriela Pittis, Livio Capus · 2003 · Neurology
The iron-binding protein lactotransferrin is present in pathologic lesions in a variety of neurodegenerative disorders: a comparative immunohistochemical analysis
Béatrice Leveugle, Geneviève Spik, Daniel P. Perl, Constantin Bouras, Howard M. Fillit, Patrick R. Hof · 1994 · Brain Research
The role of copper ions in pathophysiology and fluorescent sensors for the detection thereof
Peter Verwilst, Kyoung Sunwoo, Jong Seung Kim · 2015 · Chemical Communications
Dysregulation of Iron Homeostasis in the Central Nervous System and the Role of Ferroptosis in Neurodegenerative Disorders
Samuel David, Priya Jhelum, Fari Ryan, Suh Young Jeong, Antje Kroner · 2021 · Antioxidants and Redox Signaling
Targeting Molecular Mediators of Ferroptosis and Oxidative Stress for Neurological Disorders
Jing Li, Bowen Jia, Ying Cheng, Yiting Song, Qianqian Li, Chengliang Luo · 2022 · Oxidative Medicine and Cellular Longevity
The effect of a synthetic neuromelanin on yield of free hydroxyl radicals generated in model systems
Mariusz Zaręba, Agnieszka Bober, Witold Korytowski, Luigi Zecca, Tadeusz Sarna · 1995 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Free radicals in Alzheimer’s disease
Wolfgang Retz, Wieland Gsell, Gerald W Münch, Michael Rösler, Peter Franz Riederer · 1998 · Journal of neural transmission. Supplementum
Novel bifunctional drugs targeting monoamine oxidase inhibition and iron chelation as an approach to neuroprotection in Parkinson?s disease and other neurodegenerative diseases
Youdim, M. B. H., Fridkin, M., Zheng, H. · 2004 · Journal of Neural Transmission
Does cellular iron dysregulation play a causative role in Parkinson’s disease?
Kaur, Deepinder, Andersen, Julie · 2004 · Ageing Research Reviews
Selective cell death in neurodegeneration: Why are some neurons spared in vulnerable regions?
Kay L. Double, Stefanie Reyes, Eryn L. Werry, Glenda Margaret Halliday · 2010 · Progress in Neurobiology
Lipid Peroxides in the Free Radical Pathophysiology of Brain Diseases
A. A. Farooqui, Lloyd A. Horrocks · 1998 · Cellular and Molecular Neurobiology
Cellular distribution of the iron-binding protein lactotransferrin in the mesencephalon of Parkinson's disease cases
Béatrice Leveugle, Baptiste A. Faucheux, Constantin Bouras, Nathalie Nillesse, Geneviève Spik, Étienne C. Hirsch, Yves Agid, Patrick R. Hof · 1996 · Acta Neuropathologica
Modifications of the iron–neuromelanin system in Parkinson's disease
Mauro Fasano, Bruno Bergamasco, Leonardo Lopiano · 2006 · Journal of Neurochemistry
Lack of up-regulation of ferritin is associated with sustained iron regulatory protein-1 binding activity in the substantia nigra of patients with Parkinson's disease
Faucheux, Baptiste A., Martin, Marie‐Elise, Beaumont, Carole, Hunot, Stéphane, Hauw, Jean‐Jacques, Agid, Yves, Hirsch, Etienne C. · 2002 · Journal of Neurochemistry
Volume and iron content in basal ganglia and thalamus
Patrice Péran, Andrea Cherubini, Giacomo Luccichenti, Gisela Elisabeth Hagberg, Jean‐François Démonet, Olivier Rascol, Pierre Celsis, Carlo Caltagirone, Gianfranco Spalletta, Umberto Sabatini · 2009 · Human Brain Mapping
Mitochondrial iron metabolism and neurodegenerative diseases
Ruiying Cheng, Varun V. Dhorajia, Jonghan Kim, Yuho Kim · 2021 · NeuroToxicology
The roles of neuromelanin, binding of metal ions, and oxidative cytotoxicity in the pathogenesis of Parkinson's disease: A hypothesis
W S Enochs, Tadeusz Sarna, Luigi Zecca, Patrick Anthony Riley, Harold M. Swartz · 1994 · Journal of Neural Transmission - Parkinsons Disease and Dementia Section
Mechanisms of neurodegeneration shared between multiple sclerosis and Alzheimer’s disease
Lassmann, Hans · 2011 · Journal of Neural Transmission
Neuromelanin and its interaction with iron as a potential risk factor for dopaminergic neurodegeneration underlying Parkinson's disease
Manfred Gerlach, Kay L. Double, Dorit Ben‐Shachar, Luigi Zecca, Moussa B. H. Youdim, Peter Franz Riederer · 2003 · Neurotoxicity Research
Parkinson's disease as multifactorial oxidative neurodegeneration: implications for integrative management.
P M Kidd · 2000 · PubMed
Potential sources of increased iron in the substantia nigra of parkinsonian patients
M. Gerlach, Kay L. Double, Moussa B. H. Youdim, Peter Franz Riederer · 2006 · Springer eBooks
The Involvement of Iron in Traumatic Brain Injury and Neurodegenerative Disease
Maria Daglas, Paul Anthony Adlard · 2018 · Frontiers in Neuroscience
To Eat or to Die: Deciphering Selective Forms of Autophagy
Alibek Abdrakhmanov, Vladimir G. Gogvadze, Boris Zhivotovsky · 2020 · Trends in Biochemical Sciences
MPTP and 6-hydroxydopamine-induced neurodegeneration as models for Parkinson’s disease: neuroprotective strategies
Edna Grünblatt, Silvia A. Mandel, Moussa B. H. Youdim · 2000 · Journal of Neurology
Infusion of iron into the rat substantia nigra: Nigral pathology and dose‐dependent loss of striatal dopaminergic markers
Gregory J. Sengstock, C. Warren Olanow, Robert A. Menzies, Adrian J. Dunn, Gary W. Arendash · 1993 · Journal of Neuroscience Research
A review of the pharmacology of selegiline
E. H. Heinonen, Risto A. S. Lammintausta · 1991 · Acta Neurologica Scandinavica
Influence of neuromelanin on oxidative pathways within the human substantia nigra
Double, K.L, Ben-Shachar, D, Youdim, M.B.H, Zecca, L, Riederer, P, Gerlach, M · 2002 · Neurotoxicology and Teratology
Iron in parkinsonian and control substantia nigra—A mössbauer spectroscopy study
Jolanta Gałązka-Friedman, Erika R. Bauminger, A. Friedman, Maria Barcikowska, Daniel Hechel, I. Nowik · 1996 · Movement Disorders
Pathophysiology of Parkinson's disease
A.M. Bonnet, Jean‐Luc Houéto · 1999 · Biomedicine & Pharmacotherapy
Oxidative Stress, Redox Imbalance, and the Aging Process
Tory M. Hagen · 2003 · Antioxidants and Redox Signaling
Impaired iron homeostasis in Parkinson’s disease
Kay L. Double, M. Gerlach, Moussa B. H. Youdim, Peter Franz Riederer · 2000 · Springer eBooks
Physiological and Pathological Role of Alpha-synuclein in Parkinson’s Disease Through Iron Mediated Oxidative Stress; The Role of a Putative Iron-responsive Element
Olivares, David, Huang, Xudong, Branden, Lars, Greig, Nigel H., Rogers, Jack T. · 2009 · International Journal of Molecular Sciences
Identification of a dysfunctional microglial population in human Alzheimer’s disease cortex using novel single-cell histology image analysis
Molly E. V. Swanson, Emma L. Scotter, Leon C. D. Smyth, Helen C. Murray, Brigid Ryan, Clinton P. Turner, Richard L. M. Faull, Mike Dragunow, Maurice A. Curtis · 2020 · Acta Neuropathologica Communications
Neuroprotective Strategies in Parkinson's Disease Using the Models of 6‐Hydroxydopamine and MPTPa
Edna Grünblatt, Silvia A. Mandel, Moussa B. H. Youdim · 2000 · Annals of the New York Academy of Sciences
An Orally Active Catalytic Metalloporphyrin Protects against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine NeurotoxicityIn Vivo
Liping Liang, Jie Huang, Ruth E. Fulton, Brian J. Day, Manisha Patel · 2007 · Journal of Neuroscience
Genetic contributions to Parkinson's disease
Yue Ming Huang, Linda Cheung, Dominic B. Rowe, Glenda Margaret Halliday · 2004 · Brain Research Reviews
Iron‐sulfur enzyme mediated mitochondrial superoxide toxicity in experimental Parkinson's disease
Liping Liang, Manisha Patel · 2004 · Journal of Neurochemistry
Neuronal Death: Is There a Role for Astrocytes?
Maria Teresa Tacconi · 1998 · Neurochemical Research
Increased Susceptibility of Alzheimer's Disease Temporal Cortex to Oxygen Free Radical-Mediated Processes
Laura J. McIntosh, Michael A. Trush, Juan Carlos Troncoso · 1997 · Free Radical Biology and Medicine
Magnetic Resonance Imaging Evidence of Decreased Putamenal Iron Content in Idiopathic Parkinson's Disease
Philippe Ryvlin, Emmanuel Broussolle, Henri Piollet, François Viallet, Y. Khalfallah, Guy Chazot · 1995 · Archives of Neurology
Review: Iron metabolism and the role of iron in neurodegenerative disorders
Maya Hadzhieva, Elmar Kirches, Christian Mawrin · 2013 · Neuropathology and Applied Neurobiology
Voxel‐based analysis of R2* maps in the healthy human brain
Patrice Péran, Gisela Elisabeth Hagberg, Giacomo Luccichenti, Andrea Cherubini, Valentina Brainovich, Pierre Celsis, Carlo Caltagirone, Umberto Sabatini · 2007 · Journal of Magnetic Resonance Imaging
Ferritin stimulates oligodendrocyte genesis in the adult spinal cord and can be transferred from macrophages to NG2 cells in vivo
D. Schonberg, Evan Z. Goldstein, F. R. Sahinkaya, Ping Wei, P. Popovich, D. McTigue · 2012 · Journal of Neuroscience
Magnetic resonance imaging of brain iron in health and disease
Josef Vymazal, Rodney A. Brooks, Nicholas J. Patronas, Milan Hájek, Jeff W. M. Bulte, Giovanni Di Chiro · 1995 · Journal of the Neurological Sciences
Distribution of iron in different brain regions and subcellular compartments in Parkinson's disease
Peter Franz Riederer, Albrecht Dirr, Mario E. Goetz, Emin Sofic, K. A. Jellinger, M. B. H. Youdimt · 1992 · Annals of Neurology
Neuroprotection and dopamine agonists
Anthony H.V. Schapira · 2002 · Neurology
Oxidation-induced ferritin turnover in microglial cells: role of proteasome
Jana Mehlhase, Grit Sandig, Kostas Pantopoulos, Tilman Grune · 2004 · Free Radical Biology and Medicine
Copper and iron in Alzheimer's disease: a systematic review and its dietary implications
Martin Loef, Harald Walach · 2011 · British Journal Of Nutrition
Anti-melanin antibodies are increased in sera in Parkinson's disease
Kay L. Double, Dominic B. Rowe, Francine Carew‐Jones, M. Hayes, Daniel Kam Yin Chan, Jeffrey Blackie, Alastair J. Corbett, Ron Joffe, Victor S.C. Fung, John G. Morris et al. · 2009 · Experimental Neurology
Mitochondrial Iron Sequestration in Dopamine‐Challenged Astroglia: Role of Heme Oxygenase‐1 and the Permeability Transition Pore
Hyman M. Schipper, Lise Bernier, Khalil Mehindate, Dov Frankel · 1999 · Journal of Neurochemistry
The Pivotal Role of Iron in NF‐κB Activation and Nigrostriatal Dopaminergic Neurodegeneration: Prospects for Neuroprotection in Parkinson's Disease with Iron Chelators
Moussa B. H. Youdim, Edna Grünblatt, Silvia A. Mandel · 1999 · Annals of the New York Academy of Sciences
Induction of Nitric Oxide Synthase and Microglial Responses Precede Selective Cell Death Induced by Chronic Impairment of Oxidative Metabolism
Noel Ylagan Calingasan, Larry C.H. Park, L. L. Calo, Rosario Rich Trifiletti, Sam Gandy, Gary E. Gibson · 1998 · American Journal Of Pathology
Manganese exposure induces microglia activation and dystrophy in the substantia nigra of non-human primates
Tatyana Verina, Samara Flamini Kiihl, Jay S. Schneider, Tomás R. Guilarte · 2010 · NeuroToxicology
Elevation of antioxidant potency in the brain of mice by low-dose γ-ray irradiation and its effect on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced brain damage
Shuji Kojima, Osamu Matsuki, Takaharu Nomura, Kiyonori Yamaoka, M. Takahashi, Etsuo Niki · 1999 · Free Radical Biology and Medicine
Acute and chronic effects of developmental iron deficiency on mRNA expression patterns in the brain
Stacey Lynn Clardy, X. Wang, Wei Zhao, W. Liu, Gary A. Chase, J. L. Beard, Barbara True Felt, James R. Connor · 2006 · Springer eBooks
Distribution of divalent metal transporter-1 in the monkey basal ganglia
E. Huang, Wei‐Yi Ong, James R. Connor · 2004 · Neuroscience
Biochemistry of Parkinson's disease with special reference to the dopaminergic systems
Étienne C. Hirsch · 1994 · Molecular Neurobiology
Nitric Oxide, Iron and Neurodegeneration
Chao Liu, Mui Cheng Liang, Tuck Wah Soong · 2019 · Frontiers in Neuroscience
Rg1 reduces nigral iron levels of MPTP-treated C57BL6 mice by regulating certain iron transport proteins
Jun Wang, Huamin Xu, Haidong Yang, Xixun Du, Hong Fu Jiang, Junxia Xie · 2008 · Neurochemistry International
Metallobiology of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity
Hare, Dominic J., Adlard, Paul A., Doble, Philip A., Finkelstein, David I. · 2013 · Metallomics
Influence of regional iron on the motor impairments of Parkinson's disease: A quantitative susceptibility mapping study
Xiaojun Guan, Min Xuan, Quanquan Gu, Xiaojun Xu, Peiyu Huang, Nian Wang, Zhujing Shen, Jingjing Xu, Wei Feng Luo, Minming Zhang · 2016 · Journal of Magnetic Resonance Imaging
Cliniconeuropathologic correlations show astroglial albumin storage as a common factor in epileptogenic vascular lesions
Anna Raabe, Ann Kristin Schmitz, Katharina Pernhorst, Alexander Grote, Christian von der Brelie, Horst Urbach, Alon Friedman, Albert J. Becker, Christian Erich Elger, Pitt Niehusmann · 2012 · Epilepsia
Intranasal administration of α-synuclein preformed fibrils triggers microglial iron deposition in the substantia nigra of Macaca fascicularis
Jianjun Guo, Feng Yue, Dong‐Yan Song, Luc Bousset, Xin Liang, Jing Tang, Lin Yuan, Wen Li, Ronald Melki, Yong Cheng Tang et al. · 2021 · Cell Death and Disease
Parkinson’s disease multimodal imaging: F-DOPA PET, neuromelanin-sensitive and quantitative iron-sensitive MRI
Frédérique Depierreux, Éric Parmentier, Laurane Mackels, Katherine Baquero, Christian Degueldre, Evelyne Balteau, Éric Salmon, Christophe L. M. Phillips, Mohamed Ali Bahri, Pierre Maquet et al. · 2021 · npj Parkinson s Disease
Microglial pathology in Down syndrome
Qing‐Shan Xue, Wolfgang J. Streit · 2011 · Acta Neuropathologica
Selective MAO-A and B inhibitors, radical scavengers and nitric oxide synthase inhibitors in Parkinson's desease
Moussa B. H. Youdim, Lena Lavie · 1994 · Life Sciences
Glial HO-1 expression, iron deposition and oxidative stress in neurodegenerative diseases
Schipper, Hyman M. · 1999 · Neurotoxicity Research
Metal Chelation Therapy and Parkinson’s Disease: A Critical Review on the Thermodynamics of Complex Formation between Relevant Metal Ions and Promising or Established Drugs
Marianna Tosato, Valerio Di Marco · 2019 · Biomolecules
Alzheimer’s Disease and Green Tea: Epigallocatechin-3-Gallate as a Modulator of Inflammation and Oxidative Stress
Víctor Valverde-Salazar, Daniel Ruiz-Gabarre, Vega García‐Escudero · 2023 · Antioxidants
Effect of mitochondrial complex I inhibition on Fe–S cluster protein activity
Natalia P. Mena, Anne‐Laure Bulteau, Julio Salazar, Étienne C. Hirsch, Marco Tulio Núñez · 2011 · Biochemical and Biophysical Research Communications
An altered blood–brain barrier contributes to brain iron accumulation and neuroinflammation in the 6-OHDA rat model of Parkinson’s disease
Sonia Olmedo‐Díaz, Héctor M. Estévez-Silva, Greger Orädd, Sara af Bjerkén, Daniel J. Marcellino, Ana Virel · 2017 · Neuroscience
Iron as the concert master in the pathogenic orchestra playing in sporadic Parkinson’s disease
Peter Franz Riederer, Camelia Monoranu, Sabrina Strobel, T. Iordache, Jeswinder Sian‐Hülsmann · 2021 · Journal of Neural Transmission
Iron accumulation induces oxidative stress, while depressing inflammatory polarization in human iPSC-derived microglia
Boyd Kenkhuis, Michelle van Eekeren, David A. Parfitt, Yavuz Ariyürek, Poulomi Banerjee, Josef Priller, Louise van der Weerd, Willeke van Roon‐Mom · 2022 · Stem Cell Reports
Insights into the pathogenesis of multiple system atrophy: focus on glial cytoplasmic inclusions
Seiji Kaji, Takakuni Maki, Tomoyuki Ishimoto, Hodaka Yamakado, Ryōsuke Takahashi · 2020 · Translational Neurodegeneration
Cell specific quantitative iron mapping on brain slices by immuno-µPIXE in healthy elderly and Parkinson’s disease
Isabel Friedrich, Katja Reimann, Steffen Jankuhn, Evgeniya P. Kirilina, Jens Stieler, Mandy Sonntag, J. Meijer, Nikolaus Weiskopf, T. Reinert, Thomas Arendt et al. · 2021 · Acta Neuropathologica Communications
cDNA microarray to study gene expression of dopaminergic neurodegeneration and neuroprotection in MPTP and 6-hydroxydopamine models: implications for idiopathic Parkinson’s disease
Silvia A. Mandel, Edna Grünblatt, Moussa B. H. Youdim · 2000 · Springer eBooks
EPR investigations of the iron domain in neuromelanin
Silvio Aime, Bruno Bergamasco, Daniele Biglino, Giuseppe Digilio, Mauro Fasano, Elio Giamello, Leonardo Lopiano · 1997 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
High-field Magnetic Resonance Imaging of Brain Iron in Alzheimer Disease
John F. Schenck, Earl A. Zimmerman, Zhu Li, Sudeshna Adak, Angshuman Saha, Reeti Tandon, Kenneth Michael Fish, Clifford J. Belden, Robert W. Gillen, A Barba et al. · 2006 · Topics in Magnetic Resonance Imaging
Astroglial and microglial contributions to iron metabolism disturbance in Parkinson's disease.
N. Song, Jun Wang, Hong Jiang, Jun-Xia Xie · 2018 · Biochimica et Biophysica Acta - Molecular Basis of Disease
Transferrin and HFE genes interact in Alzheimer's disease risk: the Epistasis Project
Donald J. Lehmann, Maaike Schuur, Donald R. Warden, Naomi Hammond, Olivia Belbin, Heike Kölsch, Michael G. Lehmann, Gordon Keith Wilcock, Kristelle S. Brown, Patrick G. Kehoe et al. · 2010 · Neurobiology of Aging
Neuroprotective and neurotoxic roles of levodopa (L-DOPA) in neurodegenerative disorders relating to Parkinson's disease
Richard M. Kostrzewa, John P. Kostrzewa, R Brus · 2002 · Amino Acids
Intrapallidal lipopolysaccharide injection increases iron and ferritin levels in glia of the rat substantia nigra and induces locomotor deficits
J. Zhang, D.M. Stanton, Xuan V. Nguyen, M. Liu, Z. Zhang, Don Marshall Gash, Guoying Bing · 2005 · Neuroscience
Ageing neuroinflammation and neurodegeneration
Roberta J. Ward · 2015 · Frontiers in Bioscience-Scholar
Dopaminergic cell death precedes iron elevation in MPTP-injected monkeys
Yi He, P.S.P. Thong, Timothy T. Lee, Seng Kee Leong, Bo yong Mao, Fang Dong, F. Watt · 2003 · Free Radical Biology and Medicine
Neuroprotection by dopamine agonists
Klaus W. Lange, Wolf‐Dieter Rausch, Wieland Gsell, Naumann, M., Eveline M. Oestreicher, Peter Franz Riederer · 1994 · PubMed
A brief history of brain iron accumulation in Parkinson disease and related disorders
Paul Bernard Foley, Dominic James Hare, Kay L. Double · 2022 · Journal of Neural Transmission
ELISA reveals a difference in the structure of substantia nigra ferritin in Parkinson's disease and incidental Lewy body compared to control
Dariusz Koziorowski, Andrzej Friedman, Paolo Arosio, Paolo Santambrogio, Dorota Dziewulska · 2007 · Parkinsonism & Related Disorders
Astrocyte Mitochondria: A Substrate for Iron Deposition in the Aging Rat Substantia Nigra
Hyman M. Schipper, Rachelle Vininsky, Richard Brull, Lorne Small, James R. Brawer · 1998 · Experimental Neurology
Early and Late Gene Changes in MPTP Mice Model of Parkinson's Disease Employing cDNA Microarray
Silvia A. Mandel, Edna Grünblatt, Gila Maor, Moussa B. H. Youdim · 2002 · Neurochemical Research